MSD's pulmonary arterial hypertension (PAH) drug Winrevair has been accelerating at a breakneck pace since its launch earlier this year – and data from a new phase 3 study could give it a turbo boost.

This week Kyle drives the all-new Chevrolet Silverado EV Trail Boss and the Silverado 1500 diesel. Mike ponders over the direction of MINI during a test drive of the Cooper S 4-Door, while Kyle drives ...